Advent of New Technologies help Vaccine Market Grow

Research and Markets have announced the addition of 'Vaccines: Emerging Technologies, Trends, and Market Opportunities, 2nd Edition' to their offering.

(PRWEB) November 13, 2003 --
Vaccines: Emerging Technologies, Trends, and Market Opportunities, 2nd Edition

New technologies in the vaccine market will heighten competition and spur additional opportunities and growth.

Historically, vaccines have been treated as commodity products - now the advent of new technologies and the potential for patented technologies and products has infused life into the business - along with new profit potential due to improved pricing possibilities and higher margins. With well over 1,000 vaccines in research and development worldwide for infectious diseases, cancer, and other diseases, vaccines have become the fastest growing segment of the pharmaceutical industry. D&MD's thoroughly revised and updated version of its best-selling 1998 report, Vaccines: Emerging Technologies, Trends, and Market Opportunities, will inform you of the latest developments in vaccine technologies and how they will continue to play a critical role in the successful formulation of vaccines.

Unique Benefits of this Report:

1. Examination of the underpinnings of the fastest growing segment in the pharmaceutical industry, outlining key trends in the vaccines market

2. Analysis of the leading technologies and delivery systems driving emerging opportunities in vaccine development, putting you a step ahead of competitors

3. Comprehensive analysis of infectious disease and cancer market segments, identifying where the greatest opportunities lie

4. In-depth profiles of leading biopharmaceutical companies developing and delivering vaccines, highlighting industry leaders and strategy insights

5. Evaluation of the impact of vaccine strategic alliances, mergers, and acquisitions restructuring the market, recognizing the impact of the key collaborations

6. Discussion of the many issues that may prevent effective safety, reimbursement, distribution, and utilization of vaccines, informing you of possible obstacles to overcome

Without the development and use of new vaccines and continued emphasis on global prevention using existing vaccines, more and more of the population is at risk of contracting new diseases and diseases that were previously under control. The changing environment and increased travel between industrialized nations and developing countries will continuously enable the rapid spread, sharing of, and resultant mutation of microbial genetic information. How to ensure the future of those microbes with the potential consequence of both the resurgence of old infections and the rise of new outbreaks is hitherto unknown.

1. How are pharmaceutical industry trends driving growth in the vaccine segment?

2. What are the environmental issues that will impact the vaccine market?

3. How is the business model of successful vaccine companies evolving to ensure profitability?

4. What is the potential for profit in the vaccine market?

5. Which companies are positioned to take advantage of near-term growth opportunities?

6. What role will the government play in structuring the market, and how can changes in government outlook alter the business structure to potentiate growth?

7. Which segments of the market will support the fastest growth?

For a complete index of this report click on http://www.researchandmarkets.com/reports/39132

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com
###